S-(4-硝基芐基)-6-硫代肌苷
|
|
|
- CAS號(hào):
- 38048-32-7
- 英文名:
- S-(4-NITROBENZYL)-6-THIOINOSINE
- 英文別名:
- NBMPR;NBTI;NSC 296962;nitrobenzylthioinosine;4-nitrobenzylthioinosine;6-(p-nitrobenzylthio)inosine;S6-(4-nitrylbenzyl)thioinosine;S-(4-NITROBENZYL)-6-THIOINOSINE;S-(P-NITROBENZYL)-6-THIOINOSINE;4-Nitrobenzyl-6-mercaptoinosine
- 中文名:
- S-(4-硝基芐基)-6-硫代肌苷
- 中文別名:
- S-(4-硝基芐基)-6-硫肌苷;S-(4-硝基芐基)-6-硫代肌苷;S-(4-硝基芐基)-6-硫代肌苷;(S)-(4-硝基苯甲基)-6-硫肌苷;6-[(4-硝基芐基)硫代]-9-Β-D-呋喃核糖基嘌呤;6-[(4-硝基芐基)硫代]-9-Β-D-呋喃核糖基嘌呤;S-(4-硝基芐基)-6-硫代肌苷,10 MM DMSO 溶液
- CBNumber:
- CB8713230
- 分子式:
- C17H17N5O6S
- 分子量:
- 419.41
- MOL File:
- 38048-32-7.mol
|
|
|
S-(4-硝基芐基)-6-硫代肌苷化學(xué)性質(zhì)
-
熔點(diǎn):
-
187-190 °C(lit.)
-
|
-
沸點(diǎn):
-
770.2±70.0 °C(Predicted)
-
|
-
密度:
-
1.3904 (rough estimate)
-
|
-
折射率:
-
1.6460 (estimate)
-
|
-
儲(chǔ)存條件:
-
2-8°C
-
|
-
溶解度:
-
0.1 M HCl: slightly soluble
-
|
-
形態(tài):
-
solid
-
|
-
酸度系數(shù)(pKa):
-
13.08±0.70(Predicted)
-
|
-
顏色:
-
white
-
|
-
CAS 數(shù)據(jù)庫:
-
38048-32-7(CAS DataBase Reference)
-
|
S-(4-硝基芐基)-6-硫代肌苷性質(zhì)、用途與生產(chǎn)工藝
用途
極強(qiáng)的核苷轉(zhuǎn)運(yùn)抑制劑。在培養(yǎng)中，NBMPR可牢固但可逆地結(jié)合到與核苷轉(zhuǎn)運(yùn)機(jī)制相關(guān)的腫瘤細(xì)胞膜位點(diǎn)上，因此是一種可用于癌癥研究的有用工具。
S-(4-硝基芐基)-6-硫代肌苷
上下游產(chǎn)品信息
上游原料
下游產(chǎn)品
| 更新日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱 | CAS編號(hào) | 包裝 | 價(jià)格 |
|---|
| 2024/11/08 | S0838 | S-(4-硝基芐基)-6-硫代肌苷
NBMPR | 38048-32-7 | 5mg | 3988.53元 |
| 2024/11/08 | S0838 | S-(4-硝基芐基)-6-硫代肌苷
NBMPR | 38048-32-7 | 25mg | 12031.1元 |
S-(4-硝基芐基)-6-硫代肌苷
生產(chǎn)廠家
38048-32-7, S-(4-硝基芐基)-6-硫代肌苷 相關(guān)搜索:
- Sulfur & Selenium Compounds
- Nucleotides
- Inhibitors
- Heterocycles
- Bases & Related Reagents
- 抑制劑
- 藥靶配體
- 合成
- C17H17N5O6S
- S-(4-硝基芐基)-6-硫代肌苷,10 MM DMSO 溶液
- 6-[(4-硝基芐基)硫代]-9-Β-D-呋喃核糖基嘌呤
- S-(4-硝基芐基)-6-硫代肌苷
- (S)-(4-硝基苯甲基)-6-硫肌苷
- S-(4-硝基芐基)-6-硫肌苷
- 6-[(4-硝基芐基)硫代]-9-Β-D-呋喃核糖基嘌呤
- S-(4-硝基芐基)-6-硫代肌苷
- 38048-32-7
- Nitrobenzylthioinosine, 10 mM in DMSO
- S6-(4-nitrylbenzyl)thioinosine
- NBMPR
- Inosine, 6-S-[(4-nitrophenyl)methyl]-6-thio-
- (2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-((4-nitrobenzyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol
- S-(4-Nitrobenzyl)-6-thioinosine,99%
- 6-[[(4-Nitrophenyl)methyl]thio]-9-(β-D-ribofuranosyl)-9H-purine
- 6-[(4-Nitrobenzyl)thio]-9-β-D-ribofuranosyl-9H-purine
- 4-Nitrobenzyl-6-mercaptoinosine
- NBMPR, NBTI, 6-[(4-Nitrobenzyl)thio]-9-β-D-ribofuranosylpurine
- S-(p-Nitrobenzyl)-6-mercapto-9--D-ribofuranosylpurine
- NSC 296962
- 6-S-[(4-Nitrophenyl)methyl]-6-thioinosine
- 6-[(4-Nitrobenzyl)-mercapto]-inosine
- 6-[(4-nitrobenzyl)thio]-9-β-d-ribofuranosylpurine
- S-(4-Nitrobenzyl)-6-thioinosine (NBTI, NBMPR)
- S-(P-NITROBENZYL)-6-THIOINOSINE 98+%
- S-(4-NITROBENZYL)-6-THIOINOSINE (NBTI) P OTENT ADENOSINE UPTA
- nitrobenzylthioinosine
- 6-[(4-NITROBENZYL)THIO]-9-BETA-D-RIBOFURANOSYLPURINE
- 6-(p-nitrobenzylthio)inosine
- 6-(((4-nitrophenyl)methyl)thio)-9-beta-d-ribofuranosyl-9h-purine
- 6-(((4-nitrophenyl)methyl)thio)-9-beta-d-ribofuranosyl-9h-purin
- 4-nitrobenzylthioinosine
- NBTI
- S-(4-NITROBENZYL)-6-THIOINOSINE
- S-(P-NITROBENZYL)-6-THIOINOSINE